Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 09:20:08 UTC |
---|
Update Date | 2021-09-26 23:03:56 UTC |
---|
HMDB ID | HMDB0251742 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Eleclazine |
---|
Description | Eleclazine belongs to the class of organic compounds known as benzoxazepines. These are organic compounds containing a benzene fused to an oxazepine ring (a seven-membered ring with four carbon atoms, one oxygen atom, and a nitrogen atom). Eleclazine is an extremely weak basic (essentially neutral) compound (based on its pKa). Eleclazine has been used in trials studying the treatment of LQT2 Syndrome, Long QT Syndrome, Ischemic Heart Disease, Ventricular Arrhythmia, and Long QT Syndrome Type 3, among others. This compound has been identified in human blood as reported by (PMID: 31557052 ). Eleclazine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Eleclazine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | FC(F)(F)OC1=CC=C(C=C1)C1=CC=C2OCCN(CC3=NC=CC=N3)C(=O)C2=C1 InChI=1S/C21H16F3N3O3/c22-21(23,24)30-16-5-2-14(3-6-16)15-4-7-18-17(12-15)20(28)27(10-11-29-18)13-19-25-8-1-9-26-19/h1-9,12H,10-11,13H2 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C21H16F3N3O3 |
---|
Average Molecular Weight | 415.372 |
---|
Monoisotopic Molecular Weight | 415.114375876 |
---|
IUPAC Name | 4-[(pyrimidin-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one |
---|
Traditional Name | 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | FC(F)(F)OC1=CC=C(C=C1)C1=CC=C2OCCN(CC3=NC=CC=N3)C(=O)C2=C1 |
---|
InChI Identifier | InChI=1S/C21H16F3N3O3/c22-21(23,24)30-16-5-2-14(3-6-16)15-4-7-18-17(12-15)20(28)27(10-11-29-18)13-19-25-8-1-9-26-19/h1-9,12H,10-11,13H2 |
---|
InChI Key | YNUAEEJQYHYLMS-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzoxazepines. These are organic compounds containing a benzene fused to an oxazepine ring (a seven-membered ring with four carbon atoms, one oxygen atom, and a nitrogen atom). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzoxazepines |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzoxazepines |
---|
Alternative Parents | |
---|
Substituents | - Benzoxazepine
- Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- Monocyclic benzene moiety
- Pyrimidine
- Benzenoid
- Heteroaromatic compound
- Tertiary carboxylic acid amide
- Trihalomethane
- Carboxamide group
- Lactam
- Carboxylic acid derivative
- Ether
- Oxacycle
- Azacycle
- Organofluoride
- Organohalogen compound
- Hydrocarbon derivative
- Alkyl fluoride
- Organic nitrogen compound
- Halomethane
- Organic oxide
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Alkyl halide
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Eleclazine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9017000000-9b49b800ddff11e04869 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Eleclazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 10V, Positive-QTOF | splash10-014i-1005900000-b7e3dddbceddb1ff3f93 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 20V, Positive-QTOF | splash10-000i-3029200000-8a160f7bf549224d42df | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 40V, Positive-QTOF | splash10-0udl-8191000000-808f6100fc34a90fae9f | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 10V, Negative-QTOF | splash10-03di-0001900000-4e197e0eca4290a5a008 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 20V, Negative-QTOF | splash10-03di-0109200000-f4445098850fa176469a | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 40V, Negative-QTOF | splash10-001i-9660000000-62ffe9d471b7447bc840 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 10V, Positive-QTOF | splash10-014i-0000900000-60f43999150ae815733c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 20V, Positive-QTOF | splash10-014i-3001900000-415f9c08f1855799b1a3 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 40V, Positive-QTOF | splash10-0006-9456000000-77052c8ed130e32a71aa | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 10V, Negative-QTOF | splash10-03di-0000900000-99d4fb9a690629703632 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 20V, Negative-QTOF | splash10-03di-1009500000-cb2212a66bf93894afdd | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eleclazine 40V, Negative-QTOF | splash10-03dl-9388400000-b776cea3689b095fd1f3 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|